Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,309.50
-13.00 (-0.98%)
Jun 27, 2025, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 80.69 billion as of June 27, 2025. Its market cap has decreased by -34.65% in one year.
Market Cap
80.69B
Enterprise Value
59.41B
Revenue
22.30B
Ranking
n/a
PE Ratio
10.33
Stock Price
1,309.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 80.69B, an increase of 2,090.25%. That is a compound annual growth rate of 13.31%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,913.01B |
| Coloplast | 135.87B |
| Demant | 57.05B |
| ALK-Abelló | 40.90B |
| H. Lundbeck | 34.12B |
| Ambu A/S | 26.64B |
| Zealand Pharma | 25.09B |
| GN Store Nord | 14.14B |